227 related articles for article (PubMed ID: 24833610)
21. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.
Belton A; Gabrovsky A; Bae YK; Reeves R; Iacobuzio-Donahue C; Huso DL; Resar LM
PLoS One; 2012; 7(1):e30034. PubMed ID: 22276142
[TBL] [Abstract][Full Text] [Related]
22. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
[TBL] [Abstract][Full Text] [Related]
23. High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria.
Esposito F; Tornincasa M; Federico A; Chiappetta G; Pierantoni GM; Fusco A
Cell Death Dis; 2012 Aug; 3(8):e383. PubMed ID: 22932725
[TBL] [Abstract][Full Text] [Related]
24. H19 promotes the migration and invasion of colon cancer by sponging miR-138 to upregulate the expression of HMGA1.
Yang Q; Wang X; Tang C; Chen X; He J
Int J Oncol; 2017 May; 50(5):1801-1809. PubMed ID: 28358427
[TBL] [Abstract][Full Text] [Related]
25. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
Cao XP; Cao Y; Zhao H; Yin J; Hou P
Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
[TBL] [Abstract][Full Text] [Related]
26. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas.
Masciullo V; Baldassarre G; Pentimalli F; Berlingieri MT; Boccia A; Chiappetta G; Palazzo J; Manfioletti G; Giancotti V; Viglietto G; Scambia G; Fusco A
Carcinogenesis; 2003 Jul; 24(7):1191-8. PubMed ID: 12807722
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice.
Di Cello F; Shin J; Harbom K; Brayton C
Biochem Biophys Res Commun; 2013 Apr; 434(1):70-4. PubMed ID: 23545254
[TBL] [Abstract][Full Text] [Related]
28. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
Hillion J; Dhara S; Sumter TF; Mukherjee M; Di Cello F; Belton A; Turkson J; Jaganathan S; Cheng L; Ye Z; Jove R; Aplan P; Lin YW; Wertzler K; Reeves R; Elbahlouh O; Kowalski J; Bhattacharya R; Resar LM
Cancer Res; 2008 Dec; 68(24):10121-7. PubMed ID: 19074878
[TBL] [Abstract][Full Text] [Related]
29. Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis.
Mellone M; Rinaldi C; Massimi I; Petroni M; Veschi V; Talora C; Truffa S; Stabile H; Frati L; Screpanti I; Gulino A; Giannini G
Neoplasia; 2008 Aug; 10(8):773-81. PubMed ID: 18670638
[TBL] [Abstract][Full Text] [Related]
30. MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.
Wang CQ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3771-3778. PubMed ID: 31115003
[TBL] [Abstract][Full Text] [Related]
31. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
[TBL] [Abstract][Full Text] [Related]
32. A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
Pegoraro S; Ros G; Ciani Y; Sgarra R; Piazza S; Manfioletti G
Oncotarget; 2015 Aug; 6(22):19087-101. PubMed ID: 26265440
[TBL] [Abstract][Full Text] [Related]
33. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.
Schuldenfrei A; Belton A; Kowalski J; Talbot CC; Di Cello F; Poh W; Tsai HL; Shah SN; Huso TH; Huso DL; Resar LM
BMC Genomics; 2011 Nov; 12():549. PubMed ID: 22053823
[TBL] [Abstract][Full Text] [Related]
34. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
Liau SS; Rocha F; Matros E; Redston M; Whang E
Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
[TBL] [Abstract][Full Text] [Related]
35. Functional relationship between high mobility group A1 (HMGA1) protein and insulin-like growth factor-binding protein 3 (IGFBP-3) in human chondrocytes.
Gasparini G; De Gori M; Paonessa F; Chiefari E; Brunetti A; Galasso O
Arthritis Res Ther; 2012 Oct; 14(5):R207. PubMed ID: 23036517
[TBL] [Abstract][Full Text] [Related]
36. HMGA1 controls transcription of insulin receptor to regulate cyclin D1 translation in pancreatic cancer cells.
Kolb S; Fritsch R; Saur D; Reichert M; Schmid RM; Schneider G
Cancer Res; 2007 May; 67(10):4679-86. PubMed ID: 17510394
[TBL] [Abstract][Full Text] [Related]
37. The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1.
Massimi I; Guerrieri F; Petroni M; Veschi V; Truffa S; Screpanti I; Frati L; Levrero M; Gulino A; Giannini G
Mol Carcinog; 2013 Jul; 52(7):526-34. PubMed ID: 22389255
[TBL] [Abstract][Full Text] [Related]
38. Dynamic mitochondrial localization of nuclear transcription factor HMGA1.
Dement GA; Treff NR; Magnuson NS; Franceschi V; Reeves R
Exp Cell Res; 2005 Jul; 307(2):388-401. PubMed ID: 15893306
[TBL] [Abstract][Full Text] [Related]
39. Silencing of HMGA1 expression by RNA interference suppresses growth of osteogenic sarcoma.
Yuan S; Pan Q; Fu C; Bi Z
Mol Cell Biochem; 2011 Sep; 355(1-2):281-7. PubMed ID: 21573994
[TBL] [Abstract][Full Text] [Related]
40. Fra-1 Regulates the Expression of HMGA1, Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma.
Toyozumi T; Hoshino I; Takahashi M; Usui A; Akutsu Y; Hanari N; Murakami K; Kano M; Akanuma N; Suitoh H; Matsumoto Y; Sekino N; Komatsu A; Matsubara H
Ann Surg Oncol; 2017 Oct; 24(11):3446-3455. PubMed ID: 27882471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
